Hidradenitis suppurativa in sexual and gender minorities: A review and considerations for providers.
HIV/AIDS
LGBTQIA health
gender identity
hidradenitis suppurativa
inflammation/inflammatory
medical dermatology
sexual and gender minorities
sexuality
squamous cell carcinoma
Journal
Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
12
10
2021
revised:
26
01
2022
accepted:
01
03
2022
medline:
20
9
2023
pubmed:
15
3
2022
entrez:
14
3
2022
Statut:
ppublish
Résumé
The literature on hidradenitis suppurativa in sexual and gender minorities remains sparse. This review article aims to discuss critical factors for providers to consider in lesbian, gay, bisexual, transgender, queer, intersex, and asexual patients with hidradenitis suppurativa, including associated comorbidities, gender-affirming hormonal therapy, squamous cell carcinoma, infections in HIV-positive patients, and creating a welcoming clinic for sexual and gender minority patients.
Identifiants
pubmed: 35283243
pii: S0190-9622(22)00385-1
doi: 10.1016/j.jaad.2022.03.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
795-801Informations de copyright
Copyright © 2022 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest Maria Aleshin - received research funding from UCB, consultant for Abbvie.